JAN 14, 2021 6:00 AM PST

Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics

WRITTEN BY: Tara Fernandes

Only 10 percent of icebergs are visible on the water's surface; the remaining 90 percent remains submerged. Similarly, UCLA researchers have found that there could be more to prostate tumors than what is visible in diagnostic images. A study published in the Journal of Urology highlights how magnetic resonance imaging (MRI), commonly used to visualize prostate tumors, often does not paint an accurate picture of tumor size. This disconnect in information can lead to inadequate cancer interventions.

MRI uses powerful magnetic forces and radiofrequency waves to construct incredibly detailed 3-dimensional visual representations of internal body structures such as organs, bones, and tissues. In some techniques, the addition of a contrast medium helps enhance the clarity and resolution of the images generated. 

MRI-based procedures are standard practice in the diagnosis and management of prostate cancer. It allows oncologists to analyze the tumor's physical characteristics, which informs which clinical intervention would likely be most effective for eliminating the cancerous tissue—from cryotherapy to laser ablation.

Scientists at the UCLA Jonsson Comprehensive Cancer Center found that this approach might not be as effective as once thought. In a study of over 400 participants, the found that the underestimation of tumor size was particularly pronounced for smaller masses, which had low PI-RADS scores (a scoring system from 1 to 5 used to determine the clinical significance of MRI images of the prostate). To maximize the chances of success, the MRI size measurements and PI-RADS scores must line up, allowing physicians to discern the cancerous tissues from the normal, healthy tissues that border it.

Prostate cancer is the most common cancer in men in the United States. Around 60 percent of cases are diagnosed in men over 65. By improving the ability to differentiate between healthy and malignant tissues, the authors anticipate more successful treatments and a reduction in the number of lives lost from the disease.

 

Source: Journal of Urology.


 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
JUN 14, 2022
Coronavirus
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
JUN 14, 2022
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
Labroots hosted its 3rd annual Coronavirus Conference Virtual Event Series on May 4, 2022. The speaker roster for this f ...
JUL 10, 2022
Neuroscience
Brain Injuries in Kids May Lead to Cognitive Problems
JUL 10, 2022
Brain Injuries in Kids May Lead to Cognitive Problems
When children or teens experience a severe blow to the head, like one that might be sustained in a car accident, fall, o ...
JUL 26, 2022
Microbiology
Child Hepatitis Cases Linked to Viral Co-Infection
JUL 26, 2022
Child Hepatitis Cases Linked to Viral Co-Infection
Between April 5 and May 26 of 2022, hundreds of cases of viral hepatitis in children were diagnosed in 33 countries, acc ...
AUG 02, 2022
Cardiology
Exercising 150-600 Minutes Per Week Leads to Lowest Death Risk
AUG 02, 2022
Exercising 150-600 Minutes Per Week Leads to Lowest Death Risk
People who exercise for two to four times the recommended amount per week see major reductions in all-cause mortality.
AUG 03, 2022
Cardiology
Cardiovascular diseases could see sharp increase in US by 2060
AUG 03, 2022
Cardiovascular diseases could see sharp increase in US by 2060
In a recent study published in the Journal of the American College of Cardiology, a collaborative research team from the ...
AUG 08, 2022
Cancer
A Protein Detectable in Blood Linked to Diabetes Onset and Cancer Mortality
AUG 08, 2022
A Protein Detectable in Blood Linked to Diabetes Onset and Cancer Mortality
Type 2 diabetes (T2D) is a well-established risk factor associated with some types of cancer, including liver, pancreas, ...
Loading Comments...